UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043821
Receipt number R000050013
Scientific Title A study of causative microorganisms and usefulness of various tests in patients with suspected COVID-19
Date of disclosure of the study information 2021/04/03
Last modified on 2021/04/02 16:26:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of causative microorganisms and usefulness of various tests in patients with suspected COVID-19

Acronym

A study of causative microorganisms and usefulness of various tests in patients with suspected COVID-19

Scientific Title

A study of causative microorganisms and usefulness of various tests in patients with suspected COVID-19

Scientific Title:Acronym

A study of causative microorganisms and usefulness of various tests in patients with suspected COVID-19

Region

Japan


Condition

Condition

COVID-19

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination of causative microorganisms

Basic objectives2

Others

Basic objectives -Others

Evaluation of the usefulness of the test

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

FilmArray Respiratory Panel 2.1 Test Results (including SARS-CoV2)

Key secondary outcomes

Presence of other microbial infections in SARS-CoV-2 PCR-positive patients
SARS-CoV-2 PCR results by GeneSoC.
Test results of FilmArray Respiratory Panel 2.1 compared to SARS-CoV-2 PCR
Sensitivity, Specificity and Minimum Detection Sensitivity of SARS-CoV-2 Antibody Test Reagent Kits (IgM, IgG) and COVID-19 IgG/IgM Immunochromatographic Kit


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients suspected to have COVID-19 and underwent SARS-CoV2 PCR test during the study period (after Ethics Committee approval - March 31, 2022)
Selection Criteria
1. patients with pneumonia requiring hospitalization who need to be differentiated from COVID-19
Patients who have been in contact with a confirmed COVID-19 patient or have traveled to an endemic area within 14 days of onset and require hospitalization.
2. Patients with fever of 37.5 degree or higher and symptoms such as cough, sputum, sore throat, chest pain, dyspnea, malaise, arthralgia, myalgia, anorexia, and diarrhea
3. Acute onset taste or smell disorder
Definition of endemic areas: Areas with COVID-19 infections of 0.3/100,000 population or more in the last week. 4.
4. patients aged 20 years or older at the time of nasopharyngeal swab specimen collection

Key exclusion criteria

1. If the participant is judged to be ineligible for research.
2. those who refuse to participate in the research

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tatsuya
Middle name
Last name Fukumori

Organization

Nara Medical University

Division name

Center for Infectious Diseases

Zip code

634-8522

Address

840 Shijo-Cho, Kashihara, Nara, Japan

TEL

0744-22-3051

Email

t-fukumori@naramed-u.ac.jp


Public contact

Name of contact person

1st name Tatsuya
Middle name
Last name Fukumori

Organization

Nara Medical University

Division name

Center for Infectious Diseases

Zip code

634-8522

Address

840 Shijo-Cho, Kashihara, Nara, Japan

TEL

0744-22-3051

Homepage URL


Email

t-fukumori@naramed-u.ac.jp


Sponsor or person

Institute

Nara Medical University
Center for Infectious Diseases

Institute

Department

Personal name



Funding Source

Organization

KYORIN Holdings, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University Bioethics Supervision Office

Address

840 Shijo-Cho, Kashihara, Nara, Japan

Tel

0744-22-3051

Email

t-fukumori@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 03 Month 19 Day

Date of IRB

2020 Year 03 Month 27 Day

Anticipated trial start date

2020 Year 03 Month 27 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective observational study


Management information

Registered date

2021 Year 04 Month 02 Day

Last modified on

2021 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050013


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name